PCCA, a supplier of pharmaceutical ingredients, has achieved a milestone by becoming the first FDA-registered supplier to have its compounding bases verified by the U.S. Pharmacopeia (USP). The company's proprietary products, LoxOral and Anhydrous SuspendIt, have undergone the USP Ingredient Verification Program for Excipients, which involves rigorous testing and quality control evaluations.
The verification highlights PCCA's dedication to industry standards and regulatory compliance. "This validation milestone demonstrates our 'Quality without Compromise' core value in action," stated PCCA CEO Gus Bassani. He emphasized that independent verification reinforces their commitment to pharmacies and patients.
LoxOral is designed for oral capsules, facilitating easy mixing with active pharmaceutical ingredients. Anhydrous SuspendIt is a water-free oral base offering improved taste and broader applications. Holly Chang from USP remarked on PCCA’s accomplishment as a commitment to quality.
PCCA plans to seek further verifications for additional proprietary bases. As an advocate for personalized medicine, PCCA continues to provide high-quality products and support to over 3,000 pharmacy members globally.
Alerts Sign-up